undamentalytics Newsletter
Sign in

Neuroone Medical Technologies Corp income statement

In fiscal 2025, Neuroone Medical Technologies Corp reported revenue of $9.1m, up 163.5% on the year before, operating income of −$4.2m (a -46.5% margin) and net income of −$3.6m, or −$0.09 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20102012Dec 20112013Dec 20122014Dec 20132015Dec 20142016Dec 20152017Dec 20162021Sept 20212022Sept 20222023Sept 20232024Sept 20242025Sept 2025LTMJun 2026
Revenue0000000002399
Cost of revenue—0—————001244
Gross profit0000———−0−00155
Research and development———————457555
Selling, general and administrative———————677878
General and administrative0000000——————
Operating income——−0−0−0−0−0−10−10−12−12−4−8
Interest expense—−0−0—00—0—————
Net interest income———————−0—————
Income before tax——−0−0−0−0−0—−10−12−12−4−7
Income tax————000−0—————
Net income−0−0−0−0−0−0−0−10−10−12−12−4−7
Diluted EPS—−$0.03$0.00−$0.03−$0.03−$0.03−$0.03−$0.93−$0.63−$0.65−$0.46−$0.09—
Diluted shares (average)1m2m2m2m2m2m2m11m16m18m27m40m—
EBITDA———————−10−10−12−12−4−8

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MLSS vs NMTCNMTC vs WOKNMTC vs NUWENMTC vs NNNN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Neuroone Medical Technologies Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neuroone Medical Technologies Corp.